Hydroponics Company Ltd share price up 5% on Canadian news

The Hydroponics Company Ltd (ASX:THC) share price has risen by 5% today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Hydroponics Company Ltd (ASX: THC) share price has risen by 5% today on an update regarding Canadian expansion.

Hydroponics Company is one of the larger pot stocks on the ASX and has grown strongly along with the rest of the industry in recent times.

Today, the business has advised that it has appointed accounting and legal advisors to commence due diligence on a Canadian acquisition. When the acquisition is completed it is expected that the Canadian's company revenues will be in excess of C$20 million per annum.

The acquisition will compliment the existing Crystal Mountain-Dragon Vision (CMDV) business and provides exposure to the growing Licenced Producers in eastern Canada.

Management also said that CMDV is trying to boost organic growth opportunities with new agencies to the portfolio. The business has updated its website to better reflect this increased portfolio.

The Hydroponics Company CEO, David Radford, said "upon completion of this acquisition The Hydroponics Company will offer an extensive range of products for the Canadian cannabis market. This growth of the Canadian company was identified in October as being a strategic imperative and I am pleased with the progress being made in executing this strategy".

If this acquisition succeeds it will complete in late April 2018. The company will continue to look for further opportunities, both acquisitive and organic to drive growth in the Canadian market.

Foolish takeaway

The share price has risen by 49% over the past month and could keep rising if more positive announcements like this one happen in regards to Canadian expansion.

I'm not a buyer of pot stocks at the moment, I think there's too much hype for how much revenue is on the horizon in the near term. However, in the long-term these prices may be justified.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »